A dynamic model for assessing universal Hepatitis A vaccination in Canada (Q40251047)

18 September 2017

title

A dynamic model for assessing universal Hepatitis A vaccination in Canada (English)

1 reference

18 September 2017

0 references

1 reference

M Krahn

4

0 references

author name string

C T Bauch

1

1 reference

18 September 2017

Arni S R Srinivasa Rao

2

1 reference

18 September 2017

B Z Pham

3

1 reference

18 September 2017

V Gilca

5

1 reference

18 September 2017

B Duval

6

1 reference

18 September 2017

M H Chen

7

1 reference

18 September 2017

A C Tricco

8

1 reference

18 September 2017

language of work or name

English

0 references

publication date

27 November 2006

1 reference

18 September 2017

1 reference

18 September 2017

volume

25

1 reference

18 September 2017

issue

10

1 reference

18 September 2017

page(s)

1719-1726

1 reference

Epidemiological patterns of hepatitis A in different parts of the world

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.020

Hepatitis A: old and new.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.020

Frequency of illness associated with epidemic hepatitis A virus infections in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.020

Hepatitis A vaccines: the growing case for universal immunisation of children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.020

HAV infection in chronic liver disease: a rationale for vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.020

The cost-effectiveness of adolescent hepatitis A vaccination in states with the highest disease rates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.020

Ineffectiveness of the current strategy to prevent hepatitis A in travelers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.020

Hepatitis A virus infections in urban children--are preventive opportunities being missed?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.020

Hepatitis A virus infections in the United States: model-based estimates and implications for childhood immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.020

Hepatitis A in day-care centers. A community-wide assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.020

Sources of infection among persons with acute hepatitis A and no identified risk factors during a sustained community-wide outbreak

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.020

Incidence of hepatitis A in the United States in the era of vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.020

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.020

Quantifying the impact of hepatitis A immunization in the United States, 1995-2001.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.020

Evaluating the cost-effectiveness of vaccination programmes: a dynamic perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.020

The spread and persistence of infectious diseases in structured populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.020

Species coexistence and periodicity in host-host-pathogen models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.020

Seroprevalence of hepatitis A infection in a low endemicity country: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.020

Hepatitis A, B, and C in Canada. Results from the National Sentinel Health Unit Surveillance System, 1993-1995.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.020

Economic evaluation of vaccination programs: the impact of herd-immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.020

Hepatitis A vaccination during an outbreak among gay men in Montréal, Canada, 1995-1997.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.020

A military community outbreak of hepatitis type A related to transmission in a child care facility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.020

Serologic investigation of an outbreak of hepatitis A in a rural day-care center

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.020

A community-wide outbreak of hepatitis A in a religious community: impact of mass administration of immune globulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.020

Contact Surface Models for Infectious Diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.020

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.020

Hepatitis A in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.020

Prevention of hepatitis A with the hepatitis A vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.020

Cost-effectiveness of hepatitis A-B vaccine versus hepatitis B vaccine for healthcare and public safety workers in the western United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.020

Protection against hepatitis A by an inactivated vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.020

A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.020

Relapsing hepatitis A. Review of 14 cases and literature survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.020

inferred from DOI database lookup

7 January 2021

based on heuristic

Prevalence of antibodies to hepatitis A antigen in patients attending a clinic for treatment of sexually transmitted diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.11.020

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2006.11.020

1 reference

release_yrkzigauzzdznasz25zb66x53i

18 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yrkzigauzzdznasz25zb66x53i

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference